Skip to main content

Blog

Dyne Announces Phase 3 Trial of Z-Rostudirsen, Plans for Submitting Biologics License Application to FDA

...

NEW: Livestream with the PAAC

...

GEMMABio Announces Duchenne Muscular Dystrophy Program, Shares Preclinical Data for Investigational Gene Therapy for Duchenne

...

REGENXBIO Shares Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202

...

Exercise in Dystrophinopathy: What Families Need to Know

...

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne

...

Momentum Continues: Duchenne Newborn Screening Advances Across the US

...

Entrada Reports Positive Topline Results from Phase 1/2 ELEVATE-44-201 Study in Duchenne

...

Catch up on PPMD Together: Philadelphia

...

Advancing Duchenne Newborn Screening: A Collaborative Path Forward

...